$LMND

It’s that familiar time of year again when insiders are blocked from transacting in their own stock due to pending 2nd quarter earnings. At least two of the notable buys were stocks The Insiders Fund is already pretty heavily invested in: Exxon and Biohaven. So, at least, the research toll on me will be minimal as I’ve spent this blistering weekend supervising a landscape project at my house. That’s the featured image if you’re wondering what that has to do with stocks. It doesn’t.   Name: Maria S. Dreyfus Position: Director Transaction Date: 2023-06-17 Shares Bought: 18,310 Average Price Paid: … Read more